Experience and enlightenment of pricenegotiation mechanism in the process of drug access for rare diseases in UKYUAN Ni, ZHOU Na, YANG Yong, SONG Hai, WANG Yong481-486
Comparison of new drug research of Chinese and Japanese classical prescriptions from the perspective of patent analysisXIN Xue, HUANG Da-zhi487-493
Institutional arrangement of innovative incentives for orphan drugs in the background of healthy ChinaWAN Zhi-qian, RAN Guang-qing494-499
General considerations on selection of relevant species in non-clinical studies of antibody productsSHAO Xue, GONG Xin-jiang, HU Xiao-min, WANG Hai-xue, SUN Tao, HUANG Fang-hua, YAN Li-ping, ZHANG Min, GUANG Hong-mei, DA Hong-yuan, WANG Qing-li500-506
Research advances in the relationship between PCSK9 and the occurrence and development of various metabolic diseasesFAN Lei, CHEN Jing, REN Jin507-513
Effects of Compound Chaijin Jieyu tablets on HPA axis and inflammatory factors in rats with chronic stress depressionWANG Yu-hong, ZHANG Shang-xia, MA Ming-yue, ZHAO Hong-qing, MENG Pan, HAN Yuan-shan, WU Meng-yao, LI Zi-rong514-519
Clinical protocol design and analysis of new Chinese medicine drug for allergic rhinitisYAO He-zhi, LI Rui, CAO Wei-yi, YANG Qiao-ning, GAO Rui520-524
Recent research advance in the role of cystatin C in neurodegenerative diseasesJIANG Lu, BAO Zheng-jun, TANG Lan-ying, ZHAO Zhen, YANG Jia-hui525-529
Research progress in pathogenesis of Streptococcus pneumoniae:from nasopharyngeal colonizer to intracellular pathogenZHOU Meng-lan, YU Shu-ying, YANG Qi-wen, XU Ying-chun530-533
Chimeric antigen receptor T-cell immunotherapy for patients with hematological malignancies: a reviewLU Yi-juan, MA Ai-xia534-540